Hims & Hers Health Free Cash Flow 2020-2025 | HIMS

Hims & Hers Health free cash flow for the twelve months ending March 31, 2025 was , a year-over-year.

  • Hims & Hers Health annual free cash flow for 2024 was $0.209B, a 272.23% increase from 2023.
  • Hims & Hers Health annual free cash flow for 2023 was $0.056B, a 292.39% decline from 2022.
  • Hims & Hers Health annual free cash flow for 2022 was $-0.029B, a 17.02% decline from 2021.

Hims & Hers Health Free Cash Flow 2020-2025 | HIMS

  • Hims & Hers Health annual free cash flow for 2024 was $0.209B, a 272.23% increase from 2023.
  • Hims & Hers Health annual free cash flow for 2023 was $0.056B, a 292.39% decline from 2022.
  • Hims & Hers Health annual free cash flow for 2022 was $-0.029B, a 17.02% decline from 2021.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$46.6B
Doximity (DOCS)$11.2B
Tempus AI (TEM)$10.6B
IRhythm Technologies (IRTC)$4.3B
Inspire Medical Systems (INSP)$3.8B
Hinge Health (HNGE)$3.6B
Privia Health (PRVA)$2.4B
Schrodinger (SDGR)$1.7B
Clover Health Investments (CLOV)$1.6B
10x Genomics (TXG)$1.6B
Phreesia (PHR)$1.6B
Enovis (ENOV)$1.6B
Azenta (AZTA)$1.5B
Omnicell (OMCL)$1.3B
Evolent Health (EVH)$1.1B
Claritev (CTEV)$702M
Fulgent Genetics (FLGT)$567M
Standard BioTools (LAB)$517M
Veradigm (MDRX)$498M
Butterfly Network (BFLY)$467M
Talkspace (TALK)$435M
TruBridge (TBRG)$336M
Outset Medical (OM)$336M
Health Catalyst (HCAT)$274M
Nyxoah SA (NYXH)$266M
SOPHiA GENETICS SA (SOPH)$229M
CapsoVision (CV)$204M
Zepp Health (ZEPP)$173M
KORU Medical Systems (KRMD)$158M
Pulmonx (LUNG)$130M